Philadelphia Naval Shipyard

Award-Winning Biotech Training Program to Begin Recruitment with New Employer Partner in Life Sciences

Retrieved on: 
Wednesday, January 17, 2024

This workforce development training will support the talent needs of the rapidly growing cell and gene therapy manufacturing organization.

Key Points: 
  • This workforce development training will support the talent needs of the rapidly growing cell and gene therapy manufacturing organization.
  • "Our partnership with VintaBio marks an exciting era of Life Science development in Philadelphia.
  • “Where other companies at a similar stage may focus on degreed talent, VintaBio is widening its talent pool to include candidates who complete our training program.
  • Hiring local talent is advantageous at every stage of a company life cycle and we applaud VintaBio for recognizing this and taking action."

Award-Winning Biotech Training Program Connects Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector

Retrieved on: 
Monday, August 14, 2023

In a field that often requires PhDs or master’s degrees for most roles, the program – “Biomedical Technician Training Program: Aseptic Manufacturing” – creates opportunities for Philadelphians with at least a high school equivalency.

Key Points: 
  • In a field that often requires PhDs or master’s degrees for most roles, the program – “Biomedical Technician Training Program: Aseptic Manufacturing” – creates opportunities for Philadelphians with at least a high school equivalency.
  • The initiative is one way the region is working together to meet the talent needs in its rapidly growing cell and gene therapy sector.
  • The program connects Philadelphians to robust biomedical training at The Wistar Institute and offers program graduates a direct path to full-time, career-ladder employment as Associate Aseptic Manufacturing Technicians at Iovance.
  • Calibrated specifically to meet the needs of a burgeoning sector, the Biomedical Technician Training Program is designed for replication across industry employers.

COMCAST SPECTACOR TAKES LEAD IN VINCERA CHILDREN'S EVENT

Retrieved on: 
Saturday, April 29, 2023

PHILADELPHIA, April 29, 2023 /PRNewswire/ -- Comcast Spectacor, the sports and entertainment division of Comcast Corporation and which owns the Philadelphia Flyers, has taken the lead in sponsoring the 2023 Vincera Children's Classic, announced Vincera Foundation's Executive Director Chris Wilmot today.

Key Points: 
  • PHILADELPHIA, April 29, 2023 /PRNewswire/ -- Comcast Spectacor, the sports and entertainment division of Comcast Corporation and which owns the Philadelphia Flyers, has taken the lead in sponsoring the 2023 Vincera Children's Classic, announced Vincera Foundation's Executive Director Chris Wilmot today.
  • The event takes place next Monday May 8 at Philadelphia Country Club in Gladwyne.
  • "We are so privileged to team up with Vincera in this event, which should 'knock the socks' off Philly sports fans with Angelo's humor and passion," declared Dan Hilferty, Comcast Spectacor's new Chairman and CEO.
  • "Comcast Spectacor is also about partnering with communities and enhancing the lives of young women and men."

Comoto Family of Brands Partners with Pediatric Brain Tumor Foundation's 2022 Ride for Kids to Inspire Communities During Childhood Cancer Awareness Month

Retrieved on: 
Monday, August 29, 2022

Comoto's mission is to serve the rider, fuel the industry and inspire the community. This partnership ticks all of those boxes by encouraging the entire motorsports community--vendors*, riders, and aspiring-riders-- to channel their passion to help kids and their families fight brain cancer.

Key Points: 
  • Additionally, the company will continue to gather donations during the 2022 National Ride for Kids Day being held on September 18.
  • For over 30 years, the Ride for Kids has been a mainstay of U.S. motorcycle charity events.
  • Comoto's Ride for Kids awareness and fundraising strategy is divided into two areas of focus over the course of the summer.
  • We're able to do that because of people and partners committed to supporting families and ending childhood brain cancer.

FIVE ORGANIZATIONS PARTNER TO DESIGN NEW BIOTECH TRAINING PROGRAM TO CONNECT PHILADELPHIANS WITH QUALITY JOBS IN THE REGION'S RAPIDLY GROWING LIFE SCIENCES SECTOR

Retrieved on: 
Tuesday, August 23, 2022

PHILADELPHIA, Aug. 23, 2022 /PRNewswire/ -- Partners in Greater Philadelphia's life sciences ecosystem are collaborating to create a new workforce development training model to connect biotech jobs with a wider range of Philadelphians, including residents from disadvantaged communities. In a field that often requires PhDs or master's degrees for most roles, the program – "Biomedical Technician Training Program: Aseptic Manufacturing" – will create opportunities for Philadelphians with at least a high school equivalency. The initiative is one way the region is working together to meet the talent needs in its rapidly growing cell and gene therapy sector.

Key Points: 
  • In a field that often requires PhDs or master's degrees for most roles, the program "Biomedical Technician Training Program: Aseptic Manufacturing" will create opportunities for Philadelphians with at least a high school equivalency.
  • The initiative is one way the region is working together to meet the talent needs in its rapidly growing cell and gene therapy sector.
  • For the West Philadelphia Skills Initiative, which has extensive experience developing training programs with healthcare organizations, the entry into life sciences is an exciting evolution.
  • "Iovance is proud to be a part of the vibrant, diverse Greater Philadelphia community and rapidly growing cell therapy hub.

SmartLabs Announces Plans to Expand High-Performance Laboratory Facilities in Philadelphia

Retrieved on: 
Monday, August 1, 2022

Philadelphia has a trailblazing community of companies advancing cell & gene therapies, and SmartLabs new facilities will improve their scientific outcomes, accelerating time from discovery to commercialization.

Key Points: 
  • Philadelphia has a trailblazing community of companies advancing cell & gene therapies, and SmartLabs new facilities will improve their scientific outcomes, accelerating time from discovery to commercialization.
  • By licensing SmartLabs state-of-the-art laboratory facilities rather than investing substantial time and money in building new space, biopharma companies can focus on their science and get new treatments to patients faster.
  • We look forward to SmartLabs presence in Philadelphia R&D and to the scientific advances that will come out of their facilities.
  • SmartLabs provides in-house design, architecture, and construction management, as well as full-service lab operations and facilities management and a suite of shared amenities.

NYC REIT Sends Letter to Shareholders Comparing Credentials of Board Candidates

Retrieved on: 
Monday, May 16, 2022

New York City REIT, Inc. (NYSE: NYC) (NYC or the Company) today sent a letter to shareholders clearly comparing the credentials of its experienced and highly-qualified director nominee, Elizabeth Tuppeny, to Comrit Investments 1, LPs (Comrit) inexperienced nominee, Sharon Stern.

Key Points: 
  • New York City REIT, Inc. (NYSE: NYC) (NYC or the Company) today sent a letter to shareholders clearly comparing the credentials of its experienced and highly-qualified director nominee, Elizabeth Tuppeny, to Comrit Investments 1, LPs (Comrit) inexperienced nominee, Sharon Stern.
  • The letter includes a chart that powerfully demonstrates that the choice is clear: Elizabeth Tuppeny is the best candidate for election to the NYC Board of Directors.
  • Further, NYC advises shareholders discard the white proxy card that they may receive from Comrit.
  • Do not be distracted from what this election is really about: choosing the best qualified person to serve on the NYC Board.

Lightning eMotors Partners with Perrone Robotics to Offer Fully Autonomous Vehicle Option to Zero-Emission Fleet Customers

Retrieved on: 
Monday, May 9, 2022

We were looking for partners who could deliver autonomous capabilities to our customers today, and in the future and thats what Perrone offers, Lightning eMotors CEO Tim Reeser said.

Key Points: 
  • We were looking for partners who could deliver autonomous capabilities to our customers today, and in the future and thats what Perrone offers, Lightning eMotors CEO Tim Reeser said.
  • Lightning and Perrone are in active discussions with a number of other potential customers as well.
  • A lot of electric vehicle manufacturers are focused on just one vehicle size, and in many cases its a bespoke custom platform, Perrone Robotics, Inc. founder and CEO Paul Perrone said.
  • A video of a Lightning electric van equipped with Perrone Robotics autonomous system can be found here: https://link.assetfile.io/4njY9uifJsHAg1BPHcR52q.mp4 .

Gilbane Building Company Relocates Office to the Philadelphia Navy Yard

Retrieved on: 
Thursday, April 7, 2022

PHILADELPHIA, April 7, 2022 /PRNewswire-PRWeb/ -- Gilbane Building Company announces the relocation of its Philadelphia office. This strategic move will support Gilbane's growing workforce while effectively maintaining the increased demand for local construction services.

Key Points: 
  • PHILADELPHIA, April 7, 2022 /PRNewswire-PRWeb/ -- Gilbane Building Company announces the relocation of its Philadelphia office.
  • Gilbane opened its doors to its new office on April 4, located at 1200 Intrepid Avenue, Suite 405, Philadelphia, PA 19112.
  • The Navy Yard has seen tremendous growth over the last few years and houses more than 150 companies.
  • With a local office in the Navy Yard, Gilbane has been "Building Philadelphia" for nearly 40 years.

Simone Development: Exponential Growth In Life Sciences Lab Construction Requires Shovel-Ready Sites

Retrieved on: 
Monday, March 7, 2022

"Because of the costs associated with the essential lab infrastructure, real estate developers with vacant land near innovation corridors will benefit from cost savings and delivery-to-market advantages," said Joe Simone .

Key Points: 
  • "Because of the costs associated with the essential lab infrastructure, real estate developers with vacant land near innovation corridors will benefit from cost savings and delivery-to-market advantages," said Joe Simone .
  • Life sciences lab and innovation users typically require high-capacity power, high-velocity ducts, acid waste neutralization and tenant emergency power capacityall costly retrofits for existing buildings.
  • "The key to this success was 1,200 acres of vacant or demolition-ready land near a major urban center," said Joe Simone.
  • "The demand for new lab space shows no sign of receding," said Patricia Simone , Principal and President of Simone Management Group.